Back to Trades
Sell4
Kiniksa Pharmaceuticals International, plc
KNSA
Total Value
$2.7M
Net $1.8M sold
Sales
$1.8M
1 transaction
Company Information
- Company Name
- Kiniksa Pharmaceuticals International, plc
- Ticker Symbol
- KNSA
- CIK
- 0001730430
Insider Information
- Name
- Ragosa Mark
- Role
- Insider
- Location
- LONDON, X0
Filing Details
- Filing Date
- Dec 10, 2025
- Transaction Date
- Dec 8, 2025
- Accession Number
- 0001835458-25-000007
- Form Type
- 4
- Net Trading Amount
- -$1.8M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Dec 8, 2025 | Class A Ordinary Share | 16,164 | $11.10 | Exercise | $179.4K |
| Dec 8, 2025 | Class A Ordinary Share | 16,165 | $11.97 | Exercise | $193.5K |
| Dec 8, 2025 | Class A Ordinary Share | 10,512 | $10.76 | Exercise | $113.1K |
| Dec 8, 2025 | Class A Ordinary Share | 42,841 | $41.49 | Sale | $1.8M |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Dec 8, 2025 | Derivative | 16,164 | $11.10 | Exercise | $179.4K |
| Dec 8, 2025 | Derivative | 16,165 | $11.97 | Exercise | $193.5K |
| Dec 8, 2025 | Derivative | 10,512 | $10.76 | Exercise | $113.1K |
Footnotes
- (F1)This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.
- (F2)This transaction was executed in multiple trades through a broker-dealer at prices ranging between $41.20 and $42.08. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- (F3)The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 7, 2022.
- (F4)The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2022.
- (F5)The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2023.